McKesson (MCK) vs ZeroStack (ZSTK)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 9, 2026.
Summary
McKesson (MCK) has outperformed ZeroStack (ZSTK) over the past year, gaining 23.1% versus a loss of 75.7%. Over five years, MCK leads with a +355.6% price change compared with -99.9% for ZSTK. McKesson is the larger company by market cap ($109.46 billion vs $100.7 million), about 1087.0 times the size.
McKesson pays a dividend yielding 0.35%, while ZeroStack does not currently pay one.
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | MCK | ZSTK |
|---|---|---|
| Share price | $938.84 | $4.62 |
| Market cap | $109.46B | $100.70M |
| 1-day change | +0.92% | -0.43% |
| YTD return | +13.41% | -26.20% |
| 1-year return | +23.09% | -75.71% |
| 5-year return | +355.63% | -99.88% |
| P/E ratio (TTM) | 25.16 | — |
| Forward P/E | 18.61 | — |
| EPS (TTM) | $37.31 | $-43.81 |
| Dividend yield | 0.35% | 0.00% |
| Annual dividend | $3.28 | $0.00 |
| Revenue (latest FY) | $403.43B | — |
| Revenue growth (YoY) | +12.36% | — |
| Net income (latest FY) | $4.76B | — |
| Gross margin | 3.61% | — |
| Operating margin | 1.54% | — |
| Net margin | 1.18% | — |
| 52-week high | $999.00 | $20.45 |
| 52-week low | $723.68 | $1.32 |
| Distance from 52-week high | -6.02% | -77.41% |
| Analyst consensus | buy | none |
| Avg. price target upside | +4.10% | +138.10% |
| Average volume | 918.02K | 486.97K |
| Shares outstanding | 116.59M | 21.80M |
| Employees | 41,600 | 21 |
| Sector | Health Care | Health Care |
| Industry | Other Pharmaceuticals | Other Pharmaceuticals |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
Key differences
- McKesson is about 1087.0 times larger than ZeroStack by market value ($109.46B vs $100.70M).
- MCK has outperformed ZSTK by 98.8 percentage points over the past year.
About McKesson
MCK stock →McKesson Corporation provides healthcare services in the United States and internationally. It operates through four segments: North American Pharmaceutical, Oncology & Multispecialty, Prescription Technology Solutions, and Medical-Surgical Solutions.
Health Care · Other Pharmaceuticals · 41,600 employees
About ZeroStack
ZSTK stock →ZeroStack Corp., through its subsidiary, Phatebo GmbH, engages in the pharmaceutical distribution business in Germany. It operates through Commercial & Wholesale and Digital Assets segments.
Health Care · Other Pharmaceuticals · 21 employees
MCK vs ZSTK FAQ
Which is bigger, McKesson or ZeroStack?
McKesson (MCK) is larger, with a market capitalization of $109.46B compared with $100.70M for ZeroStack (ZSTK).
Which stock has performed better over the past year, MCK or ZSTK?
MCK returned +23.09% over the past 12 months, compared with -75.71% for ZSTK (price return, excluding dividends). Past performance does not predict future results.
Which pays a higher dividend, McKesson or ZeroStack?
McKesson pays a dividend yielding 0.35%, while ZeroStack does not currently pay a regular dividend.
Are McKesson and ZeroStack in the same industry?
Yes. Both are classified in the Other Pharmaceuticals industry within the Health Care sector.